ClinicalTrials.Veeva

Menu

Effect of Hydrogen Gas on Hyperbaric Oxygen Toxicity

B

Blekinge Institute of Technology

Status

Not yet enrolling

Conditions

Diving Medicine
Hyperbaric Oxygen
Hyperoxia
Oxidative Stress
Oxygen Toxicity
Hydrogen-oxygen Gas
Healthy Subjects (HS)

Treatments

Other: Inhaled Hydrogen-Enriched Oxygen Gas
Other: Inhaled Nitrogen-Enriched Oxygen Gas

Study type

Interventional

Funder types

Other

Identifiers

NCT07263399
BTH-6.1.1-0165-2025
5005113/22FMV2951 (Other Grant/Funding Number)

Details and patient eligibility

About

The goal of this trial is to investigate whether adding a small fraction of hydrogen gas to an oxygen-enriched breathing mixture can reduce pulmonary oxygen toxicity (POT) in healthy and active divers from the Swedish Armed Forces. The main questions it aims to answer are:

  • Does hydrogen gas reduce oxidative stress and changes in pulmonary function associated with prolonged hyperbaric oxygen exposure?
  • What are the underlying pathophysiological mechanisms of pulmonary oxygen toxicity?

Researchers will compare oxygen-enriched breathing gas with 1-2% hydrogen to oxygen-enriched gas with 1-2% nitrogen (control) to see if hydrogen provides protective effects against POT during hyperbaric exposure.

Participants will:

  • Complete two hyperbaric exposure sessions (hydrogen vs. nitrogen), each lasting 240 minutes at 1.75 ATA
  • Undergo pulmonary function tests and sampling of blod and urin before and after each session
  • Serve as their own controls in a double-blind, randomized, crossover study design

Enrollment

32 estimated patients

Sex

All

Ages

20 to 64 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Military divers actively serving, aged 20-64 years
  • Meeting the Swedish Armed Forces physical standards for diving

Exclusion criteria

  • Ongoing infection or illness that may impact pulmonary function
  • Use of alcohol or smoking cigarettes within 48 hours
  • Diving with any breathing gas within 48 hours
  • Diving with oxygen-enriched gas (100% O₂) within 2 weeks
  • Use of medications that could affect oxidative stress, lung function, or neurological status
  • Medical history of serious diving-related injuries or long-term complications

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

32 participants in 2 patient groups

Hydrogen Gas Intervention
Experimental group
Description:
In this arm, participants will undergo a single hyperbaric exposure breathing a gas mixture composed of 98-99% oxygen and 1-2% hydrogen (H₂) at a partial pressure of 1.75 ATA for 240 minutes. The intervention aims to evaluate whether hydrogen gas has protective effects against pulmonary oxygen toxicity. Pulmonary function tests and blood and urin sampling for oxidative stress biomarkers will be performed both before and after the exposure session. The order of intervention and control exposures is randomized and the study is conducted in a double-blind fashion. A washout period of at least two weeks will follow before the control
Treatment:
Other: Inhaled Nitrogen-Enriched Oxygen Gas
Other: Inhaled Hydrogen-Enriched Oxygen Gas
Nitrogen Gas Control
Active Comparator group
Description:
In this arm, participants will undergo a single hyperbaric exposure breathing a gas mixture composed of 98-99% oxygen and 1-2% nitrogen (N₂) at a partial pressure of 1.75 ATA for 240 minutes. This exposure serves as the control condition and represents the standard oxygen-enriched breathing gas currently in use. Pulmonary function tests and blood and urin sampling for oxidative stress biomarkers will be performed both before and after the exposure session. Participants will be randomized to the order of exposures, and both participants and investigators will be blinded to the gas composition. A washout period of at least two weeks will follow before the intervention.
Treatment:
Other: Inhaled Nitrogen-Enriched Oxygen Gas
Other: Inhaled Hydrogen-Enriched Oxygen Gas

Trial documents
2

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems